z-logo
open-access-imgOpen Access
Combined deletion of p38γ and p38δ reduces skin inflammation and protects from carcinogenesis
Author(s) -
Rafal Zur,
Laura GarciaIbanez,
Ángel Nuñez-Buiza,
Noelia Aparicio,
Georgios Liappas,
Alejandra Escós,
Ana Marı́a Risco,
Angustias Page,
Cristina Sáiz-Ladera,
Dayanira AlsinaBeauchamp,
José Montáns,
Jesús M. Paramio,
Ana Cuenda
Publication year - 2015
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.4320
Subject(s) - proinflammatory cytokine , inflammation , p38 mitogen activated protein kinases , carcinogenesis , chemokine , cancer research , in vivo , medicine , immunology , biology , microbiology and biotechnology , kinase , protein kinase a , cancer
The contribution of chronic skin inflammation to the development of squamous cell carcinoma (SCC) is poorly understood. While the mitogen-activated protein kinase p38α regulates inflammatory responses and tumour development, little is known about the role of p38γ and p38δ in these processes. Here we show that combined p38γ and p38δ (p38γ/δ) deletion blocked skin tumour development in a chemically induced carcinogenesis model. p38γ/δ deletion reduced TPA-induced epidermal hyperproliferation and inflammation; it inhibited expression of proinflammatory cytokines and chemokines in keratinocytes in vitro and in whole skin in vivo, resulting in decreased neutrophil recruitment to skin. Our data indicate that p38γ/δ in keratinocytes promote carcinogenesis by enabling formation of a proinflammatory microenvironment that fosters epidermal hyperproliferation and tumourigenesis. These findings provide genetic evidence that p38γ and p38δ have essential roles in skin tumour development, and suggest that targeting inflammation through p38γ/δ offers a therapeutic strategy for SCC treatment and prevention.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom